<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>FlexiFlow: decomposable flow matching for generation of flexible molecular ensemble - Health AI Hub</title>
    <meta name="description" content="FlexiFlow introduces a novel architecture extending flow-matching models to enable the joint sampling of molecules with multiple low-energy conformations, addre">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>FlexiFlow: decomposable flow matching for generation of flexible molecular ensemble</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.17249v1" target="_blank">2511.17249v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-21
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Riccardo Tedoldi, Ola Engkvist, Patrick Bryant, Hossein Azizpour, Jon Paul Janet, Alessandro Tibo
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.17249v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.17249v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">FlexiFlow introduces a novel architecture extending flow-matching models to enable the joint sampling of molecules with multiple low-energy conformations, addressing the limitation of existing models that generate only single conformations. This approach achieves state-of-the-art results in molecular generation tasks, effectively capturing conformational diversity, and demonstrates successful transfer to protein-conditioned ligand generation, crucial for advanced drug discovery.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research significantly advances computational drug discovery by enabling the generation of not just molecules, but entire ensembles of their low-energy conformations. This allows for a more accurate and efficient prediction of drug-target binding affinity and optimization of drug properties, which is vital for identifying viable therapeutic candidates faster.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>FlexiFlow is an AI model (flow-matching) designed for *de novo* molecular generation, specifically for drug discovery. It aims to accelerate and improve the process of identifying potential drug candidates by jointly sampling molecules along with multiple conformations, which is critical for understanding their binding affinity and therapeutic properties against protein targets.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Current state-of-the-art 3D de-novo molecular generative models are restricted to producing only a single molecular conformation, overlooking the critical role of conformational landscapes in determining molecular properties and binding affinity.</li>
                    
                    <li>FlexiFlow is a novel flow-matching architecture designed for the *joint sampling* of molecules along with *multiple representative low-energy conformations*, which directly supports assessing molecular properties and designing for desired thermodynamic observables.</li>
                    
                    <li>The architecture preserves fundamental geometric properties: equivariance (invariance to rotations/translations) and permutation invariance (insensitivity to atom ordering), which are essential for robust molecular representation.</li>
                    
                    <li>FlexiFlow achieves state-of-the-art results on the QM9 and GEOM Drugs datasets, generating valid, unstrained, unique, and novel molecules that exhibit high fidelity to the training data distribution.</li>
                    
                    <li>The model effectively captures the conformational diversity of molecules, generating conformational ensembles with coverage comparable to state-of-the-art physics-based methods but at a significantly reduced inference time.</li>
                    
                    <li>FlexiFlow demonstrates successful transferability to the protein-conditioned ligand generation task, even in scenarios where the dataset provides only static protein pockets without accompanying conformational information.</li>
                    
                    <li>By enabling the generation of representative conformational ensembles, the model provides a more comprehensive basis for predicting molecular behavior and optimizing interactions with biological targets.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>FlexiFlow proposes a novel extension to existing flow-matching models, designed to perform the joint sampling of molecular structures and their multiple conformations. The architecture is engineered to intrinsically preserve both geometric equivariance (insensitivity to spatial transformations) and permutation invariance (insensitivity to atom indexing). The model's performance was evaluated on standard molecular generation tasks using the QM9 and GEOM Drugs datasets, assessing validity, uniqueness, novelty, fidelity to data distribution, and crucially, its ability to capture conformational diversity by comparing ensemble coverage and inference time against physics-based methods. Its transferability was also tested on protein-conditioned ligand generation.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>FlexiFlow achieved state-of-the-art results in molecular generation on the QM9 and GEOM Drugs datasets, demonstrating high fidelity in producing valid, unstrained, unique, and novel molecules. A key discovery is its ability to effectively capture molecular conformational diversity, generating ensembles with comparable coverage to physics-based methods at a fraction of the inference time. Furthermore, the model successfully transferred to protein-conditioned ligand generation, even when protein pocket datasets lacked explicit conformational data.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The ability of FlexiFlow to rapidly generate diverse conformational ensembles alongside novel molecules can drastically improve the efficiency of lead optimization and drug candidate screening in pharmaceutical development. This could lead to a faster identification of compounds with optimal binding characteristics and reduced off-target effects, potentially accelerating the pipeline for new therapeutic agents and ultimately bringing more effective and safer medicines to patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations or caveats regarding the FlexiFlow model's capabilities or applicability.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention specific future research directions, though its successful transferability to protein-conditioned ligand generation highlights a promising avenue for continued development and application in structure-based drug design.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmaceutical R&D</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Computational Drug Design</span>
                    
                    <span class="tag">Structural Biology</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">molecular generation</span>
                    
                    <span class="tag tag-keyword">conformational ensemble</span>
                    
                    <span class="tag tag-keyword">flow matching</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">de novo design</span>
                    
                    <span class="tag tag-keyword">3D molecular structures</span>
                    
                    <span class="tag tag-keyword">ligand design</span>
                    
                    <span class="tag tag-keyword">protein-conditioned generation</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Sampling useful three-dimensional molecular structures along with their most favorable conformations is a key challenge in drug discovery. Current state-of-the-art 3D de-novo design flow matching or diffusion-based models are limited to generating a single conformation. However, the conformational landscape of a molecule determines its observable properties and how tightly it is able to bind to a given protein target. By generating a representative set of low-energy conformers, we can more directly assess these properties and potentially improve the ability to generate molecules with desired thermodynamic observables. Towards this aim, we propose FlexiFlow, a novel architecture that extends flow-matching models, allowing for the joint sampling of molecules along with multiple conformations while preserving both equivariance and permutation invariance. We demonstrate the effectiveness of our approach on the QM9 and GEOM Drugs datasets, achieving state-of-the-art results in molecular generation tasks. Our results show that FlexiFlow can generate valid, unstrained, unique, and novel molecules with high fidelity to the training data distribution, while also capturing the conformational diversity of molecules. Moreover, we show that our model can generate conformational ensembles that provide similar coverage to state-of-the-art physics-based methods at a fraction of the inference time. Finally, FlexiFlow can be successfully transferred to the protein-conditioned ligand generation task, even when the dataset contains only static pockets without accompanying conformations.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Preprint. Code to be released upon full publication</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>